SAGE Open Medical Case Reports
Erythrocytosis and polycythemia secondary to testosterone replacement therapy in the aging male
Melanotan II shifts pigment activity inside the body, which is why the risk list is longer
As the drugs leave your system, ghrelin levels rise
HRT Safety Disclaimer: Hormone replacement therapy carries documented risks including blood clots, stroke, breast cancer, endometrial cancer (in patients with intact uterus receiving estrogen without adequate progesterone), gallbladder disease, and dementia in certain patient populations
Special Considerations and Who Should Seek Expert Coordination Patients with gastric surgeries, bariatric history, or gastrointestinal conditions need extra caution